The power crisis brewing in China may throw the Indian pharma market off gear if the situation continues for a few more months, feel sources in the local industry. Indian players roughly import 66-70 per cent of their bulk drug requirements from China.
Already, prices of active pharmaceutical ingredients (APIS), raw materials to make drugs, have gone up significantly and there are delays in shipments to India.
Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA), the umbrella organisation of big pharma players in India, said prices of APIs have started going up. “Prices of Penicillin-G from China have gone up from $14 per unit to $26 in just one month, he said, adding that India does not have large capacities to make such fermentation-based APIs.
IPA members account for 60 per cent of the domestic market and about 80 per cent of India's exports of pharmaceutical products.
Jain added that supplies are coming, but there are delays in shipments. “Apart from the power shortage problem plaguing the industry in China, there are also issues with shipping.
هذه القصة مأخوذة من طبعة October 28, 2021 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة October 28, 2021 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
PSBS classify RInfra's SPV as NPA
Several large public-sector banks (PSBS) classified loans to HK Toll Road, a special purpose vehicle (SPV) of Anil Ambani-run Reliance Infrastructure (RInfra), as nonperforming during the January-March quarter, according to sources in some of the big PSBs.
Cement stocks may remain tepid in near term
Likely weak demand over the next few months as the monsoon season gathers pace, coupled with no price hikes, may keep cement stocks tepid in the near term, believe analysts. As a strategy, however, they suggest investors accumulate related stocks on dips, encashing benefits of a rebound in the second half of the current financial year.
No poll jitters for MF scheme launches
Fund houses to provide better entry points after June 4
Scramble for ERP licence as doubts linger on mkt size
About a dozen players dive into the fray
Sunil Chhetri, Indian football's brightest star, to hang up his boots
World Cup qualifier against Kuwait on June 6 will be his last game
WATERED DOWN
As Bengaluru segues from a parched summer to torrential rains, citizen groups and authorities evaluate the city's future as India's IT capital
SUV sales drive M&M profit to beat estimates
Mahindra and Mahindra (M&M) has reported a 4 per cent jump in consolidated net profit for the fourth quarter of the 2023-24, riding on a 9 per cent year-on-year (Y-o-Y) growth in revenue to ₹35,452 crore.
Vi Q4 loss rings louder on higher finance cost
Arpu, revenue rise marginally; telco sees 4G subscriber base grow
Regulatory fee or unjust enrichment?
Regulators are empowered to levy fees for services rendered, not to impose tax-like levies to create surpluses for themselves
Netflix nears deal for NFL games, extending focus on sports events
Netflix Inc will air two National Football League games this Christmas Day, in the streaming TV giant's latest push into live events.
